Jointown Pharmaceutical Group Co., Ltd (SHA: 600998)

Market Cap	24.07B
Revenue (ttm)	147.95B
Net Income (ttm)	2.04B
Shares Out	4.91B
EPS (ttm)	0.41
PE Ratio	11.85
Forward PE	7.64
Dividend	0.19 (3.96%)
Ex-Dividend Date	Jun 7, 2024

Volume	18,477,351
Open	4.950
Previous Close	4.920
Day's Range	4.880 - 4.960
52-Week Range	4.400 - 8.950
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Jointown Pharmaceutical Group

Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines. The company was founded in 1999 and is based in Wuhan, China.

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1999
• Employees: 30,100
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2023, 600998's revenue was 150.14 billion, an increase of 6.92% compared to the previous year's 140.42 billion. Earnings were 2.17 billion, an increase of 4.27%.